Publications by authors named "Zhaodan Yan"

Claim this Profile
A
Association Between the Triglyceride-Glucose Index and All-Cause Mortality Among Patients with Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
Mengjiang Liu, Zhaodan Yan, Yi Zhang, Shengli Zhang

Diabetes Metab Syndr Obes· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N(6)-methyladenosine modification of ADGRA3 by ZC3H13 suppresses papillary thyroid cancer cell malignancy by inactivating the PI3K/Akt/mTOR signaling pathway.
Li Cai, Linghui Zhang, Zhaodan Yan

Discov Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EIF4A3-Induced Circ_0092278 Enhances Papillary Thyroid Cancer Cell Malignancy by the PI3K/Akt/mTOR Signaling Pathway.
Mengjiang Liu, Linghui Zhang, Zhaodan Yan

J Microbiol Biotechnol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of NEAT1 levels on cardiovascular events and prognosis in diabetic nephropathy patients undergoing peritoneal dialysis.
Mengjiang Liu, Zhaodan Yan, Yi Zhang, Shengli Zhang

Cell Mol Biol (Noisy-le-grand)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p/IMPA2 axis.
Mengjiang Liu, Linghui Zhang, Juping Hu, Chong Yan, Yi Zhang, Zhaodan Yan

Transl Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LINC01176 Hinders Thyroid Cancer Progression by Sponging miR-146b-5p to Enhance SGIP1.
Zhaodan Yan, Chong Yan

Endocr Metab Immune Disord Drug Targets· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis